Why the study?
Atrial fibrillation and heart failure frequently coexist with worse outcomes, but their bidirectional risk and the impact of disease sequence on mortality remain unclear.
Does the order of development of atrial fibrillation and heart failure impact mortality risk in patients with new-onset AF or HF?
Cohort (n=31,374)
Does the order of development of atrial fibrillation and heart failure impact mortality risk in patients with new-onset AF or HF?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“HF and AF have a bidirectional relationship and accelerate each other's progression so it is important to identify and treat HF early in patients with AF. In individuals with screening-detected AF, the risk of developing HF was threefold that of participants without AF and comparable to that of patients with clinically known AF. These findings suggest that asymptomatic AF is not a benign condition and highlight the need for early detection of both AF and HF.”
Atrial fibrillation and heart failure strongly predispose to each other, and their coexistence substantially increases mortality regardless of which condition develops first.
Aims Atrial fibrillation (AF) and heart failure (HF) frequently coexist, and their combination is associated with poorer outcomes. The bidirectional risk and the impact of which disease develops first on mortality remains unclear. Methods We studied 31,374 UK Biobank participants with new-onset AF or HF (2006-2022). Multivariable Cox models assessed risk factors, incidence, and mortality risk. Results The risk of developing HF was higher in patients with AF than in those without AF (45.1 vs 3.87 per 1000 person-years; aHR 3.15, 95% CI 3.0–3.31). The risk of developing AF in patients with HF was higher than in those without HF (25.4 vs. 2.27 per 1000 person-years; aHR 2.75, 95% CI 2.62 - 2.90). HF patients had a 31% higher risk of subsequent AF, compared to the risk of AF patients developing HF (p<0.05). Mortality risk was substantially higher in patients with both conditions. AF before HF conferred a nearly fourfold increased risk (aHR 3.8, 95% CI 3.5–4.2), while HF before AF more than doubled risk (aHR 2.0, 95% CI 2.1–2.6), compared to either condition alone. Regardless of which disease was diagnosed first, there was no significant difference in mortality risk (aHR 0.95, 95% CI 0.85–1.07). Conclusions AF and HF strongly predispose to each other, with HF conferring a higher relative risk for incident AF. The coexistence of both diseases substantially increases mortality regardless of which disease developed first, emphasizing the need for strategies to prevent the development of HF in patients with AF and vice versa.
No takes yet. Share an insight, caveat, or question.
Zandijk et al. (2026) conducted a cohort in Atrial Fibrillation and Heart Failure (n=31,374). Atrial fibrillation vs. Patients without atrial fibrillation was evaluated on Development of heart failure (aHR 3.15, 95% CI 3.0-3.31).
Synapse has enriched 10 related papers. Consider them for comparative context: